Skip to main content

Published locations for CV outcomes better with SGLT2 inhibitor than DPP4 inhibitor in T2DM study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CV outcomes better with SGLT2 inhibitor than DPP4 inhibitor in T2DM study

User login

  • Reset your password
  • /content/cv-outcomes-better-sglt2-inhibitor-dpp4-inhibitor-t2dm-study
  • /familypracticenews/article/151116/diabetes/cv-outcomes-better-sglt2-inhibitor-dpp4-inhibitor-t2dm
  • /internalmedicinenews/article/151116/diabetes/cv-outcomes-better-sglt2-inhibitor-dpp4-inhibitor-t2dm
  • /vascularspecialistonline/article/151116/diabetes/cv-outcomes-better-sglt2-inhibitor-dpp4-inhibitor
  • /clinicalendocrinologynews/article/151116/diabetes/cv-outcomes-better-sglt2-inhibitor-dpp4-inhibitor
  • /diabeteshub/article/151116/diabetes/cv-outcomes-better-sglt2-inhibitor-dpp4-inhibitor-t2dm-study
  • /ecardiologynews/article/151116/diabetes/cv-outcomes-better-sglt2-inhibitor-dpp4-inhibitor-t2dm-study
  • /cardiology/article/151116/diabetes/cv-outcomes-better-sglt2-inhibitor-dpp4-inhibitor-t2dm-study
  • /endocrinology/article/151116/diabetes/cv-outcomes-better-sglt2-inhibitor-dpp4-inhibitor-t2dm-study
  • /internalmedicine/article/151116/diabetes/cv-outcomes-better-sglt2-inhibitor-dpp4-inhibitor-t2dm
  • /familymedicine/article/151116/diabetes/cv-outcomes-better-sglt2-inhibitor-dpp4-inhibitor-t2dm-study
  • /type-2-diabetes-icymi/article/151116/diabetes/cv-outcomes-better-sglt2-inhibitor-dpp4-inhibitor-t2dm